Click on image to view larger version.

Figure 1 Initial dose-escalating studies with nicotine concentrations ranging from 0.05 to 5.0 µg/kg/day with regional perfusion of the ischemic limb as determined by microsphere distribution as the primary end point. The nicotine concentrations of 5.0 µg/kg/day showed the strongest angiogenic response as compared with control.